Professional Documents
Culture Documents
Introduction
• The word “thalassemia” is derived from the Greek words
“Thalassa” means the great sea. The disease was first
described by cooley in 1952.
• Thalassemia is a group of disease of hereditary hemolytic
anemia characterized by reduction in the synthesis of
hemoglobin.
• It produces hypochromic microcytic anemia due to defective
hemoglobiniziation of RBCs, hemolysis and ineffective
erythropoiesis.
Definition
• Thalassemia is a group of
genetic blood diseases that
vary widely in severity
involving decreased and
defective production of
hemoglobin
Causes
• Genetic factor
Risk factors
• Family history of
• Certain ancestry.
thalassemia.
Thalassemia occurs
Thalassemia is passed from
parents to children through most often in people of
• fatigue
• weakness
• shortness of breath
Cont…signs & symptoms
• Imaging studies
• Procedures
– Skeletal survey:
– Bone marrow
– Chest radiography:
examination:
– MRI or CT scanning
– Liver biopsy
– ECG,
– echocardiography
Antenatal investigation
• chorionic vilius sampling, which takes place about
11 weeks into pregnancy and involves removing a
tiny piece of the placenta for testing
• amniocentesis, which is usually done about 16
weeks into the pregnancy and involves removing a
sample of the fluid that surrounds the fetus
Management
• Treatments for thalassemias depend on the type
and severity of the disorder.
• Surgical Treatments
– Blood and Marrow Stem Cell Transplant
– splenectomy
Iron chelation therapy
• Iron chelation therapy is the removal of excess iron from the body with
special drugs. Chelate is from the Greek word "claw".
• Iron overload is the major cause of morbidity for thalassemia patients.
Even nontransfused patients develop iron overload secondary to
increased intestinal absorption of dietary iron. Iron overload is a leading
cause of mortality and organ injury.
• There are three drugs used for iron overload but in four regimes:
– Desferrioxamine (Desferal)
– Deferiprone (Ferriprox)
– Deferiprone and Desferrioxamine in combination
– Deferasirox (Exjade)
• It is useful to think about the toxicity of iron according to the following
relation:
• Toxicity = [tissue iron] x [patient- and tissue-specific factors] x [time]
Half-life of drug Side effects and
Agent Route Schedule Clearance
(hours) toxicity
Slow infusion:
Deferoxamine Dermatological,
intravenous or 0.5 Eight to 24 hours Renal, hepatic
(Desferal) ocular, auditory
subcutaneous
Deferasirox Gastrointestinal,
Oral 12 to 16 Once daily Hepatobiliary
(Exjade) renal, hepatic
Hematological
Three times per (neutropenia,
Deferiprone (L1) Oral 2 to 3 Renal, cardiac
day agranulocytosis),
arthropathic
Pharmacotherapy
• Antipyretics, analgesics (eg, acetaminophen)
• Antihistamines (eg, diphenhydramine)
• Chelating agents (eg, deferoxamine, deferasirox)
• Corticosteroids (eg, hydrocortisone)
• Antibacterial combinations (eg, gentamicin,
penicillin V)
• Vitamins (eg, ascorbic acid, alpha-tocopherol, folic
acid)
• Vaccines
• Growth hormone (eg, somatropin)
Nursing Management
• Nursing assessment of a child with thalassemia
include:
– Thalassemia major. Assess for severe anemia,
splenomegaly or hepatomegaly with abdominal
enlargement, frequent infections, bleeding
tendencies e.g. epistaxis, and anorexia.
– Thalassemia intermediate. Assess for anemia,
jaundice, and splenomegaly, hemosiderosis caused
by increased intestinal absorption of iron.
– Thalassemia minor. Assess for mild anemia usually
with no signs or symptoms.
Nursing Diagnoses
• Ineffective tissue perfusion related to reduced
cellular components that are essential to deliver
pure oxygen to the cells.
• Activity intolerance related to imbalance of
oxygen supply and consumption needs.
• Imbalanced nutrition: less than body
requirements related to lack of appetite.
• Ineffective family coping related to impact of the
disease to family functioning.
Nursing Care Planning and Goals
• Client will verbalize use of energy conservation principles.
• Client will verbalize reduction of fatigue, as evidenced by reports
of increased energy and ability to perform desired activities.
• Client will verbalize understanding of own disease and treatment
plan.
• Client will have a reduced risk of infection as evidenced by an
absence of fever, normal white blood cell count, and
implementation of preventive measures such as proper hand
washing.
• Client will have vital signs within the normal limit.
• Client will have a reduced risk for bleeding, as evidenced by
normal or adequate platelet levels and absence of bruises and
petechiae.
Nursing Interventions
• Activity. Assist the client in planning and prioritizing
activities of daily living (ADL); assist the client in
developing a schedule for daily activity and rest; and
stress the importance of frequent rest periods.
• Health education. Explain the importance of the
diagnostic procedures (such as complete blood
count), bone marrow aspiration and a possible
referral to a hematologist; and explain the
hematological vocabulary and the functions of blood
elements, such as white blood cells, red blood cells,
and platelets.
Cont…Nursing Interventions
• Prevent infection. Assess for local or systemic signs
of infection, such as fever, chills, swelling, pain, and
body malaise; instruct the client to avoid contact with
people with existing infections; instruct the client to
avoid eating raw fruits and vegetables and uncooked
meat; stress the importance of daily hygiene, mouth
care, and perineal care; and teach the client and
visitors the proper hand washing.
• Prevent bleeding. Assess for any frank bleeding
from the nose, gums, vagina, or urinary or
gastrointestinal tract and monitor platelet count.
Complications
• Excess iron
• Bone deformities and broken bones
• Enlarged spleen
• Infections
• Slower growth rates